RARE DISEASES A–Z · LETTER C

Charcot-Marie-Tooth Disease

Charcot-Marie-Tooth disease (CMT) is a group of inherited conditions that damage the peripheral nerves — the long nerves running from the spinal cord to the feet and hands. It is one of the most common inherited neurological disorders, yet many people have never heard of it until a family member is diagnosed.

By Dr. Mohamed Ibrahim, MD, PhD — Assistant Professor of Medicine, Transplant Nephrology, University of Maryland School of Medicine · Last reviewed: November 2026

Rare Diseases A–Z is part of the MedicalVideos.com education program. It is produced independently of sponsors, and any future sponsorship will be labelled on the hub.

In short: Charcot-Marie-Tooth disease is the commonest inherited nerve condition: damaged peripheral nerves weaken feet, legs, and later hands, and change foot shape. It progresses slowly, does not shorten life, and is managed with splints, therapy, and foot care.

The guide

The basics

Peripheral nerves are long cables, and CMT damages either the wire (the axon) or its insulation (the myelin sheath), depending on the gene. Signals to the farthest muscles — feet first, then lower legs and hands — weaken, so the small muscles waste and reflexes disappear. The classic appearance is high-arched feet with hammer toes and thin lower legs, sometimes described as an inverted bottle shape. People notice frequent ankle sprains, tripping over their own feet, difficulty running, and later trouble with buttons, keys, and handwriting. Numbness is usually mild compared with the weakness. There are many genetic types — the commonest, CMT1A, comes from a duplication of the PMP22 gene — and inheritance is usually dominant, though recessive and X-linked forms exist.

How it works

A neurologist can often suspect CMT from the examination and family history alone. Nerve conduction studies show whether the problem is mainly myelin (slow conduction) or axon (small signals), which narrows the gene search. Genetic testing then identifies the exact type in most families — starting with the PMP22 duplication for myelin-pattern disease — and a confirmed type allows relatives to be tested and ends the diagnostic search. Blood tests and, rarely, nerve biopsy are used to exclude acquired nerve diseases that can mimic CMT, such as diabetes-related or inflammatory neuropathy, because those have specific treatments that should not be missed.

Day to day

There is no treatment yet that repairs the nerve, so management is practical and effective: ankle-foot orthoses (splints) that hold the foot up transform walking for many people; custom footwear and insoles protect high-arched feet; physiotherapy maintains strength and balance, and occupational therapy helps with hand tasks and adaptive tools. Foot surgery — tendon transfers and bone realignment — helps selected people with severe deformity. Pain, when present, is managed with standard neuropathic-pain approaches. A few medicines can worsen nerve damage (the chemotherapy drug vincristine is the classic example), so keeping an up-to-date list and checking new prescriptions matters. Research into gene-based treatments for the commonest type is under way.

When to get help

Long-term care is about function: regular physiotherapy review, orthotics updated as feet change, and podiatry for pressure areas, since reduced feeling makes foot injuries easy to miss. Check feet regularly and treat breaks in the skin early. Mention new rapid worsening, marked asymmetry, or significant pain — typical CMT progresses slowly and evenly, so a change in tempo should prompt review for a second, treatable nerve problem. Before surgery, tell the anaesthetist about the diagnosis. Genetic counselling helps with family planning, and testing children is usually arranged when symptoms appear or at an age the family chooses with counsellors.

See a doctor promptly if: Sudden or rapidly progressing weakness over days to weeks is NOT typical of CMT — seek prompt assessment, as it may be a different, treatable nerve condition.

Common questions

Who were Charcot, Marie, and Tooth?

They are the French and English neurologists who described the condition in 1886 — Jean-Martin Charcot and Pierre Marie in Paris, and Howard Tooth in London, publishing independently in the same year. It has nothing to do with teeth.

Is Charcot-Marie-Tooth disease a form of multiple sclerosis?

No. It is a genetic condition of the peripheral nerves, unrelated to multiple sclerosis, which affects the central nervous system and is immune-mediated. The similar names cause frequent confusion.

Does CMT shorten life?

A normal lifespan is expected. CMT affects the nerves to the limbs, not vital organs, and breathing involvement is uncommon and usually mild. The challenges are mobility, hand function, pain, and fatigue rather than survival.

Can it be so mild that someone doesn't know they have it?

Yes — in fact it is how some families are first recognised. Mildly affected relatives may have only high arches, ankle sprains, or slightly clumsy hands and never sought a diagnosis. Genetic testing of the family often reveals several such cases.

More in Letter C

Related

Sources

This guide is general information, not medical advice. Rare diseases are individual — diagnosis and treatment depend on your own results, other conditions, and treatment history, and are set by your treating team. Never start, stop, or change a medicine because of something you read here. If you have severe breathlessness, uncontrolled bleeding, confusion, sudden weakness, or thoughts of harming yourself, seek urgent care. Orthotics, surgery, and medicine choices are individual; follow your neuromuscular team's advice.